MichaelMilesWessMD

Global Safety Officer

Dr. Wess is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Johns HopkinsMPH, 2008 - 2011
George Washington UniversityFellowship, Cardiovascular Disease, 1993 - 1995
University of Pennsylvania Health SystemFellowship, Internal Medicine, 1992 - 1993
University of Pennsylvania Health SystemResidency, Internal Medicine, 1990 - 1992
University of Pennsylvania Health SystemInternship, Internal Medicine, 1989 - 1990
Ernst &Whinney (Ernst & Young)Internship, Management Consulting, 1988 - 1989
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1989, MD
National Institutes of HealthFellowship, Research, 1985 - 1985
Argonne National LaboratoryInternship, Research, 1984 - 1984
University of Chicago, Booth School of BusinessMBA
Boston University, College of Liberal ArtsBA

Journal Articles

Clofarabine (Clolar®): Past, Present, and Future.
Kantarjian H, Jeha S, Gandhi V, Wess M and Faderl S, Leukemia and Lymphoma
Deuterioglucose: Alteration of Biodistribution by an Isotope Effect.
Gatley S, Wess M, Govoni P, Katz J, and Friedman A, Journal of Nuclear Medicine
Audiogenic Startle Reflex of Man and Its Relationship to Startle Syndrome.
Wilkins D, Hallet M, and Wess M, Brain
Evoked Motor Response Duration: Differences in Aging between Males and Females.
Wess M and Fisher M, Muscle and Nerve
Join now to see all

Abstracts/Posters

The Pharmacodynamics of Zelapar®: Confirmation of MAO-B Selectivity.
Wess M and Scott D, NeuroRx, American Society of Experimental Neurotherapeutics Meeting
Pergolide (Permax®) Monotherapy Titration in Parkinson’s Disease.
Nausieda P, Stern M, Hubble J, Silver D, Wess M, and Watts R, Movement Disorders, The 7th International Conference on Parkinson’s Disease and Movement Disorders
Effects of TBC3711, A Novel EndothelinA Antagonist, on the Hemodynamics of Normal Healthy Males.
Wess M, Mather J, and Davidson T, the 7th International Conference on Endothelin (ET-7) held, Edinburgh, Scotland
Acute Stress Enhances Activity of the GABA Receptor Gated Chloride Ion Channel in Brain.
Schwartz S, Wess M, Labrca R, Skolnick P, and Paul S, Brain Research
Join now to see all

Lectures

New Therapeutics in Parkinson’s Disease: Zelapar®.
The International Conference on Parkinson’s Disease, Beijing, China